Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling

Front Cell Dev Biol. 2022 May 4:10:893709. doi: 10.3389/fcell.2022.893709. eCollection 2022.

¹ Section of Microbiology and Applied Pathology, Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.
² Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy.
³ Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy.

No abstract available

Keywords: A2A adenosine receptor; P2X7 (purino) receptor; cancer immune therapy; nanomaterials; tumor microenvironment (TME).